top of page
HOME
ABOUT US
AURASE WOUND GEL
NEWS
PUBLICATIONS
CONTACT
EXPANDED ACCESS PROGRAM
18/08/21, 11:00
Seneca Partners invests £1.2m into biotech start-up SolasCure
Previous
Next
HOME
ABOUT US
AURASE WOUND GEL
NEWS
PUBLICATIONS
CONTACT
EXPANDED ACCESS PROGRAM
bottom of page